<?xml version="1.0" encoding="utf-8"?>
			<journal>
			<title>Iranian Journal of Basic Medical Sciences</title>
			<title_fa></title_fa>
			<short_title></short_title>
			<subject>Medical Sciences</subject>
			<web_url>https://ijbms.mums.ac.ir/</web_url>
			<journal_hbi_system_id>0</journal_hbi_system_id>
			<journal_hbi_system_user></journal_hbi_system_user>
			<journal_id_issn>2008-3866</journal_id_issn>
			<journal_id_issn_online>2008-3874</journal_id_issn_online>
			<journal_id_pii></journal_id_pii>
			<journal_id_doi></journal_id_doi>
			<journal_id_iranmedex></journal_id_iranmedex>
			<journal_id_magiran></journal_id_magiran>
			<journal_id_sid></journal_id_sid>
			<journal_id_nlai></journal_id_nlai>
			<journal_id_science></journal_id_science>
			<language>en</language>
			<pubdate>
				<type>jalali</type>
				<year>2026</year>
				<month>7</month>
				<day>1</day>
			</pubdate>
			<pubdate>
				<type>gregorian</type>
				<year>2026</year>
				<month>7</month>
				<day>1</day>
			</pubdate>
			<volume>29</volume>
			<number>7</number>
			<publish_type>online</publish_type>
			<publish_edition>1</publish_edition>
			<article_type>fulltext</article_type>
			<articleset><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Comparative evaluation of cell types for endothelialization in cardiovascular tissue engineering</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Review Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Tissue engineering represents a promising approach to overcome the limitations of current vascular grafts by promoting endothelialization. However, the successful fabrication of small-diameter (&lt;6 mm) tissue-engineered vascular grafts (TEVGs) that maintain the desired mechanical strength, biocompatibility, and long-term patency of native vessels remains a significant challenge. The development of an ideal TEVG depends largely on achieving complete endothelial coverage using appropriate autologous cells that can mimic the functional properties of native endothelium. Several studies have highlighted various autologous and stem cell sources with potential for graft endothelialization, including endothelial progenitor cells (EPCs), embryonic stem cells (ESCs), human umbilical vein endothelial cells (HUVECs), mesenchymal stem cells (MSCs), and induced pluripotent stem cells (iPSCs). Despite extensive preclinical progress, the most suitable cell source for generating stable and functional endothelium in small-diameter TEVGs remains unclear, representing a key gap in current knowledge. This review therefore evaluates the principal cell types investigated in cardiovascular tissue engineering, outlining their main advantages, limitations, and translational potential. Overall, a critical comparison of these cell sources highlights the need for further research to determine their long-term safety, durability, and suitability for clinical application in the construction of functional and durable TEVGs.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Cardiovascular tissue-engineering, Embryonic stem cells (escs), Endothelial progenitor cells- (epcs), Human umbilical vein-endothelial cells (huvecs), Induced pluripotent stem cells (ipscs), Mesenchymal stem cells- (mscs)</keyword>
				<start_page>979</start_page>
				<end_page>990</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27790.html</web_url>
			<author_list><author>
				<first_name>Mohamed</first_name>
				<middle_name></middle_name>
				<last_name>Elkawafi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mohamed.elkawafi@limu.edu.ly</email>
				<code>122183</code>
				<coreauthor>No</coreauthor>
				<affiliation>Basic Medical Sciences Program, School of Health and Medical Sciences, Libyan International University, Benghazi, Libya</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Sufyan</first_name>
				<middle_name></middle_name>
				<last_name>Elhashani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>sufyan.elhashani@manchester.ac.uk</email>
				<code>122182</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Division of Medical Education, School of Medical Sciences, University of Manchester, Manchester, United Kingdom</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Atya</first_name>
				<middle_name></middle_name>
				<last_name>Kushan</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>atya_kushan@limu.edu.ly</email>
				<code>122184</code>
				<coreauthor>No</coreauthor>
				<affiliation>Basic Medical Sciences Program, School of Health and Medical Sciences, Libyan International University, Benghazi, Libya</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Abdulla</first_name>
				<middle_name>M. A</middle_name>
				<last_name>Elmansoury</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>abdulla.elmansoury@limu.edu.ly</email>
				<code>122185</code>
				<coreauthor>No</coreauthor>
				<affiliation>Basic Medical Sciences Program, School of Health and Medical Sciences, Libyan International University, Benghazi, Libya</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Siraj</first_name>
				<middle_name></middle_name>
				<last_name>Alabeedi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>siraj_3633@limu.edu.ly</email>
				<code>122186</code>
				<coreauthor>No</coreauthor>
				<affiliation>Program of Medicine, School of Health and Medical Sciences, Libyan International University, Benghazi, Libya</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mahmoud</first_name>
				<middle_name></middle_name>
				<last_name>Aloriby</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mahmoud.aloriby@limu.edu.ly</email>
				<code>122187</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pathology, Medical Center, Libyan International University, Benghazi, Libya</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Smart micro/nanoneedles for gene delivery</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Review Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Gene therapy, a transformative field in biomedicine, holds immense promise for treating a wide range of diseases. Smart micro/nanoneedles (MNs/NNs) emerged as non-viral carriers, offering safety and reduced immunogenicity, in addition to precise and controlled gene delivery, and represent promising platforms for gene delivery. They can also be tailored to respond to specific biological or environmental triggers, enabling precise targeting and localized delivery, ensuring that therapeutic genes reach their intended destination. Despite significant progress, challenges persist in scalable manufacturing, biocompatibility and safety, and genetic cargo stability. The incorporation of artificial intelligence (AI) into design and predictive modelling offers promising and cost-effective solutions to these limitations. This review provides a comprehensive analysis of MN/NN fabrication methodologies that enable structural and functional customization, while highlighting the interdisciplinary nature of MN/NN technologies and their transformative role in the future of gene therapy.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Biomedicine, Carrier, Gene delivery, Microneedle, Nanoneedle</keyword>
				<start_page>991</start_page>
				<end_page>1011</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27860.html</web_url>
			<author_list><author>
				<first_name>Majid</first_name>
				<middle_name></middle_name>
				<last_name>Farhadi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>farhadim991@mums.ac.ir</email>
				<code>122484</code>
				<coreauthor>No</coreauthor>
				<affiliation>School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran|Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Gelareh</first_name>
				<middle_name></middle_name>
				<last_name>Karimi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>karimig991@mums.ac.ir</email>
				<code>122485</code>
				<coreauthor>No</coreauthor>
				<affiliation>School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran|Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Zahra</first_name>
				<middle_name></middle_name>
				<last_name>Salmasi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>salmasiz@mums.ac.ir</email>
				<code>122486</code>
				<coreauthor>No</coreauthor>
				<affiliation>Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran|Departments of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Somayeh</first_name>
				<middle_name></middle_name>
				<last_name>Marouzia</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>marouzis4023@mums.ac.ir</email>
				<code>122487</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fatemeh</first_name>
				<middle_name></middle_name>
				<last_name>Mosaffa</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mosaffaf@mums.ac.ir</email>
				<code>122488</code>
				<coreauthor>No</coreauthor>
				<affiliation>Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran|Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Maryam</first_name>
				<middle_name></middle_name>
				<last_name>Hashemi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>hashemim@mums.ac.ir</email>
				<code>122489</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran|Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Time-dependent modulation of FXR and Nrf2 signaling in rat models of BDL-induced cholestasis</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Farnesoid X receptor (FXR) and nuclear factor erythroid 2-related factor 2 (Nrf2) protect the liver against cholestatic injury by regulating antioxidant and anti-inflammatory pathways. Bile duct ligation (BDL) is a standard model for studying cholestatic liver disease, yet the temporal dynamics of FXR/Nrf2 signaling and their downstream mediators remain unclear. To investigate time-dependent changes in hepatic FXR, Nrf2, and downstream effectors over six weeks following BDL in rats, to identify potential preventive and therapeutic targets.Materials and Methods: Forty-nine male Wistar rats were divided into one sham-operated group and six BDL groups, sacrificed sequentially from weeks 1 to 6 post-surgery. Biochemical assays, histopathology, and molecular analyses were performed to assess dynamic changes in FXR, Nrf2, and related oxidative stress and inflammatory markers.Results: The most severe histological distortions were observed mainly at week six. Expression reductions in FXR, Superoxide Dismutase (SOD), Alpha-Glutathione S-Transferase (α-GST), and Glutamate-Cysteine Ligase Modifier Subunit (GCLM) were notable from week 1 to week 6, significantly declining in BDL rats compared to sham-operated ones. Nrf2 notably decreased at week 4 post-BDL (P-value&lt;0.05). TNF-α exhibited an increasing trend, peaking at week 6 (P&lt;0.001). FXR prominently decreased in weeks 1 and 5 (P&lt;0.001), and SOD notably decreased in week 5 (P&lt;0.05). α-GST and GCLM also markedly decreased, especially during BDL-W3 and BDL-W4 (P&lt;0.001).Conclusion: Temporal suppression of FXR/Nrf2 signaling and antioxidant defenses likely contribute to BDL-induced cholestatic injury, with a biphasic pattern across acute and sub-acute phases. These pathways may serve as therapeutic targets during disease progression.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Bile duct ligation (BDL), cholestasis, Cholestatic liver injury, Farnesoid X receptor, Nuclear factor erythroid 2-related factor 2</keyword>
				<start_page>1012</start_page>
				<end_page>1019</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27720.html</web_url>
			<author_list><author>
				<first_name>Seyed Ebrahim</first_name>
				<middle_name></middle_name>
				<last_name>Daryabari</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>ebrahimdaryabari@yahoo.com</email>
				<code>121801</code>
				<coreauthor>No</coreauthor>
				<affiliation>Evidence-based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Elmira</first_name>
				<middle_name></middle_name>
				<last_name>Jafari Afshar</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>elmirafshar72@gmail.com</email>
				<code>121800</code>
				<coreauthor>No</coreauthor>
				<affiliation>Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Azadeh</first_name>
				<middle_name></middle_name>
				<last_name>Khalili</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>a.khalili@abzums.ac.ir</email>
				<code>121802</code>
				<coreauthor>No</coreauthor>
				<affiliation>Evidence-based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran|Department of Physiology-Pharmacology-Medical Physics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Seyed Ali</first_name>
				<middle_name></middle_name>
				<last_name>Hashemi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>alihashemi@yahoo.com</email>
				<code>121805</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pathology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Parham</first_name>
				<middle_name></middle_name>
				<last_name>Samimisedeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>parhamsamimimd@gmail.com</email>
				<code>121803</code>
				<coreauthor>No</coreauthor>
				<affiliation>Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Gholamreza</first_name>
				<middle_name></middle_name>
				<last_name>Bayat</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>g.bayat@abzums.ac.ir</email>
				<code>121804</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Physiology-Pharmacology-Medical Physics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Hossein</first_name>
				<middle_name></middle_name>
				<last_name>Karim</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>h.karim@abzums.ac.ir</email>
				<code>121806</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran|Department of Cardiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Investigating the protective effect of zinc supplementation on streptozotocin-induced pancreatic beta-cell damage via the HMGB1/TLR2/MAPK pathway</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): This study investigated the protective effect of zinc supplementation on insulin release via modulation of the High Mobility Group Box 1 (HMGB1)/Toll-like receptor 2 (TLR2)/mitogen-activated protein kinase (MAPK) signaling pathway in streptozotocin (STZ)-induced pancreatic β-cell injury, a commonly used model of type 1 diabetes.Materials and Methos: Human pancreatic β-cells (1.1B4) were divided into five groups: Control, Diabetes, Diabetes + Zinc, Diabetes + Box A, and Diabetes + Zinc + Box A. Diabetes was induced with STZ (20 mM, four hours, type-1), followed by treatment with zinc (30 μM) and/or Box A (100 ng/l). Cellular oxidative stress, apoptosis, mitochondrial membrane potential (MMP), cell viability, and insulin secretion were measured. Protein expressions of HMGB1, TLR2/4, extracellular signal-regulated kinases 1/2 (ERK1/2), and c-Jun N-terminal kinase (JNK) were analyzed using western blotting.Results: Zinc supplementation restored MMP and total antioxidant status (TAS), reduced apoptotic cell death, and enhanced TLR2 and ERK1/2 expression suppressed by STZ. Combined zinc and Box A treatment markedly increased insulin secretion under both hypo- and hyperglycemic conditions.Conclusion: Zinc exerts protective effects against STZ-induced β-cell damage, likely through modulation of the HMGB1/TLR2/MAPK axis. These findings highlight the therapeutic potential of zinc supplementation in protecting pancreatic β-cell function in diabetes mellitus.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Apoptosis, Diabetes Mellitus, HMGB1 protein, Toll-like receptor 2, zinc</keyword>
				<start_page>1020</start_page>
				<end_page>1026</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27721.html</web_url>
			<author_list><author>
				<first_name>Sahin</first_name>
				<middle_name></middle_name>
				<last_name>Yesildag</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>sahin.yesildag@yahoo.com</email>
				<code>121807</code>
				<coreauthor>No</coreauthor>
				<affiliation>Faculty of Health Sciences, Department of Nutrition and Dietetics, Demiroglu Bilim University, Istanbul, Türkiye</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Elvan</first_name>
				<middle_name></middle_name>
				<last_name>Yılmaz Akyuz</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>elvan.yilmazakyuz@sbu.edu.tr</email>
				<code>121808</code>
				<coreauthor>No</coreauthor>
				<affiliation>Faculty of Hamidiye Health Sciences, Department of Nutrition and Dietetics, University of Health Sciences, Istanbul, Türkiye</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Eylem</first_name>
				<middle_name></middle_name>
				<last_name>Taskin</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>eylemtaskin@yahoo.com</email>
				<code>121809</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Faculty of Medicine, Department of Physiology, Adiyaman University, Adiyaman, Türkiye|Health Science Institute, Translational Medicine, Cukurova University, Adana, Türkiye</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Synergistic myelin regenerative, immunomodulatory and anti-inflammatory effects of vanillin and adipose derived stem cells in cuprizone animal model of multiple sclerosis</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Vanillin as a potential therapeutic agent along with transplantation of neurotrophic factors secreting cells, is considered a promising treatment for neurological disorders. In this study, the effects of vanillin in combination with human adipose derived stem cells transplantation were evaluated on oligodendrocyte differentiation, re-myelination, and motor function improvement.Materials and Methods: Female C57BL/6 mice were fed cuprizone (400 mg/kg/day) for 5 weeks to induce MS. Demyelinated mice were divided into MS, MS/vanillin, MS/stem cells, and MS/vanillin/stem cells groups. Additionally, sixteen mice were divided into control and sham groups for comparison. Motor function was assessed using the hanging wire test. Finally, serum levels of inflammatory (IL-2, IFN-γ) and anti-inflammatory (IL-10, TGF-β) factors, along with IgG, were measured by ELISA. The mean percentage of Olig2 and MOG-positive cells we determined using the immunohistochemical technique, and Luxal Fast Blue staining was performed to assess myelin density of corpus callosum.Results: The results revealed that the mean percentage of Olig2, Mog positive cells, the serum level of the IL-10 and TGF-β, myelin density, and behavior test score were significantly higher in treated groups specially in MS/vanillin/stem cells group (P≤0.01), also, the serum levels of the inflammatory factors and IgG were significantly higher in the MS group compare to treated groups (P≤0.01).Conclusion: Administration of vanillin with stem cell transplantation could be a suitable approach to accelerate the process of myelin repair in the nervous tissue.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Adipose derived stem cells, Multiple Sclerosis, Myelin, Oligodendrocyte, Vanillin</keyword>
				<start_page>1027</start_page>
				<end_page>1034</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27825.html</web_url>
			<author_list><author>
				<first_name>Sara</first_name>
				<middle_name></middle_name>
				<last_name>Gazmeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>saragazmeh73@gmail.com</email>
				<code>122339</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mohammad</first_name>
				<middle_name></middle_name>
				<last_name>Mardani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mardani@med.mui.ac.ir</email>
				<code>122338</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Nazem</first_name>
				<middle_name></middle_name>
				<last_name>Ghasemi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>n-ghasemi@med.mui.ac.ir</email>
				<code>122340</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Role of gallic acid in sarcopenia in D-galactose-treated mice</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Aging is a natural phenomenon that results in sarcopenia to impair living quality in humans. Gallic Acid (GA) has many biological activities against aging and muscle injury. Our purpose was to clarify possible mechanisms of GA on aged-relevant sarcopenia.Materials and Methods: Senescent model was established by D-galactose in mice. The senescent model was treated with GA for 10 weeks. Skeletal muscle was stained via HE to assess muscle fiber size. Oxidation indicators and inflammatory factors were detected using a spectrophotometer and ELISA. The protein expressions were tested by Western blot.Results: Our data unveiled GA enhanced muscle mass to improve grip strength and fatigue in D-galactose-induced aging mice. In serum, GA increased T-AOC, SOD and CAT levels, and decreased MDA, TNF-α, and IL-6 levels to exert its anti-oxidative and anti-inflammatory properties. In skeletal muscle, GA decreased atrogin 1, Murf-1, collagen I, and Tgf-β1 expressions to improve atrophy and fibrosis. Furthermore, GA increased Pgc-1α, Nrf-1, Beclin-1, and Bcl-2 expressions, and decreased P62 and Bax expressions to prevent skeletal muscle damage.Conclusion: GA exerted its protective effects on sarcopenia concomitant aging via moderating mitochondrial biology, enhancing autophagy and restraining apoptosis.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Aging, Apoptosis, Autophagy, Gallic acid, Mitochondrion, sarcopenia</keyword>
				<start_page>1035</start_page>
				<end_page>1042</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27759.html</web_url>
			<author_list><author>
				<first_name>Xianchu</first_name>
				<middle_name></middle_name>
				<last_name>Liu</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>liuxc645@huas.edu.cn</email>
				<code>122017</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Institute for Scientific Sports and Health Promotion, Hunan University of Arts and Science, Changde, Hunan, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Zile</first_name>
				<middle_name></middle_name>
				<last_name>Zhu</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>1622852052@qq.com</email>
				<code>122018</code>
				<coreauthor>No</coreauthor>
				<affiliation>Institute for Scientific Sports and Health Promotion, Hunan University of Arts and Science, Changde, Hunan, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ming</first_name>
				<middle_name></middle_name>
				<last_name>Liu</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>liuming0206@huas.edu.cn</email>
				<code>122019</code>
				<coreauthor>No</coreauthor>
				<affiliation>Faculty of Science, College of Furong, Hunan University of Arts and Science, Changde, Hunan, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Zhihe</first_name>
				<middle_name></middle_name>
				<last_name>Mao</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>maozhihe1729@huas.edu.cn</email>
				<code>122020</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Institute for Scientific Sports and Health Promotion, Hunan University of Arts and Science, Changde, Hunan, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Investigating the effects of taurine on Aβ-degradation proteins and neurogenesis-related genes in an LPS-induced neuroinflammatory SH-SY5Y cell model</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Taurine, a brain-abundant sulfonic acid, shows potential neuroprotective effects and may counter neurodegenerative processes. This study investigated the effects of taurine on neuroinflammation, focusing on Aβ-degrading proteins and gene expression related to neurogenesis in an LPS-stimulated SH-SY5Y cell model.Materials and Methods: The effects of taurine (0.5 and 1 mg/ml) and LPS (0.5 and 10 μg/ml) on SH-SY5Y cell viability were assessed using the MTT assay. IL-1β and IL-6 expression was measured by real-time PCR, while matrix metalloproteinases (MMPs) and angiotensin-converting enzyme (ACE) levels were quantified via ELISA. Neurogenesis-related gene expression was evaluated using the Neurogenesis Plus RT² Profiler PCR array.Results: The MTT assay results demonstrated that taurine treatment at concentrations of 0.5 and 1 mg/ml significantly attenuated the cytotoxicity induced by LPS stimulation in SH-SY5Y cells. Also, treatment with taurine significantly reduced the expression levels of the inflammatory genes IL-1β and IL-6 in LPS-stimulated SH-SY5Y cells (P&lt;0.05). ELISA results further revealed that taurine treatment significantly increased the secretion levels of ACE and MMP-9 enzymes in LPS-stimulated SH-SY5Y cells (P&lt;0.05). LPS exposure in SH-SY5Y cells significantly up-regulated genes related to apoptosis, cell migration, and synaptic function (P&lt;0.005). Conversely, taurine treatment significantly increased the expression of genes involved in cell adhesion, synaptic function, growth factors, cytokines, differentiation, cell cycle, signaling, transcription, and cofactor activity (P&lt;0.005).Conclusion: These results suggest that taurine may act as a potential neuroprotective agent by increasing the secretion of MMP-9 and ACE, regulating neurogenesis-related genes, and reducing LPS-induced neuroinflammation.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Lipopolysaccharides, Matrix metalloproteinase 9, Neurogenesis Neuroinflammatory - diseases, Neuroprotective agents Taurine</keyword>
				<start_page>1043</start_page>
				<end_page>1051</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27828.html</web_url>
			<author_list><author>
				<first_name>Pirouz</first_name>
				<middle_name></middle_name>
				<last_name>Pourmohammad</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>pirouz.pourmohammad@iau.ac.ir</email>
				<code>122354</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Biochemistry, NT.C., Islamic Azad University, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fereshteh</first_name>
				<middle_name></middle_name>
				<last_name>Rahmati</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>fereshtehrahmati20252525@gmail.com</email>
				<code>122355</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Biochemistry, NT.C., Islamic Azad University, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fatemeh</first_name>
				<middle_name></middle_name>
				<last_name>Siadat</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>f.siadat@iau-tnb.ac.ir</email>
				<code>122356</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Cellular and Molecular Biology, NT.C., Islamic Azad University, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Sara</first_name>
				<middle_name></middle_name>
				<last_name>Simorgh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>srsimorgh@gmail.com</email>
				<code>122357</code>
				<coreauthor>No</coreauthor>
				<affiliation>Stem Cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran|Department of Tissue Engineering &amp; Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Modulation of CCL5 and CXCR4 as EMT signaling biomarkers by cold atmospheric plasma and Anti-PD-1 combination therapy in melanoma: Insights from integrated bioinformatics and in vitro and in vivo validation</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Cold atmospheric plasma (CAP) has emerged as a promising non-thermal modality with anticancer effects. Combining CAP with immune checkpoint blockade (ICB) may enhance therapeutic efficacy, yet the molecular targets underlying this synergy remain incompletely understood.Materials and Methods: Epithelial–mesenchymal transition (EMT)–associated genes responsive to CAP and Anti-PD-1 therapy were identified by integrating bioinformatics analyses of melanoma transcriptomic data with in vitro and in vivo experiments. Weighted gene co-expression network analysis (WGCNA), GO, and KEGG enrichment identified key modules and candidate genes. The effects of CAP, Anti-PD-1, and their combination on cell viability and gene expression were evaluated in B16F10 melanoma cells, L929 fibroblasts, and a syngeneic mouse melanoma model.Results: WGCNA highlighted CCL5 and CXCR4 as hub genes enriched in EMT-related pathways. MTT assays showed that CAP reduced B16F10 cell viability, an effect further enhanced by Anti-PD-1, while sparing L929 fibroblasts. In tumor-bearing mice, combination therapy produced the most pronounced tumor regression and down-regulation of CCL5 and CXCR4 compared with single treatments. Minimal viability or expression changes were observed in normal fibroblasts or untreated controls.Conclusion: CAP and Anti-PD-1 combination therapy effectively suppressed melanoma cell viability and modulated EMT-associated gene expression both in vitro and in vivo. We further explored a potential molecular mechanism underlying this therapeutic effect, revealing that the EMT-related genes CCL5 and CXCR4 play a vital role in this response. These findings highlight the relevance of these pathways and support the potential of combining CAP with ICB as a promising approach for melanoma treatment.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Anti-PD-1, C-X-C chemokine receptor - type 4 (CXCR4), C-C motif chemokine ligand - 5 (CCL5), Cold atmospheric plasma - (CAP), Epithelial-mesenchymal - transition (EMT), Melanoma</keyword>
				<start_page>1052</start_page>
				<end_page>1065</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27810.html</web_url>
			<author_list><author>
				<first_name>Zeinab</first_name>
				<middle_name></middle_name>
				<last_name>Rostami</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>zeinabrostamy73@gmail.com</email>
				<code>122258</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran|Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fatemeh</first_name>
				<middle_name></middle_name>
				<last_name>Akhundi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>akhoundi.fatemeh68@gmail.com</email>
				<code>122259</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Zahra</first_name>
				<middle_name></middle_name>
				<last_name>Yazdani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>zahrayazdanikachooi1391@gmail.com</email>
				<code>122260</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran|Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mohammad</first_name>
				<middle_name></middle_name>
				<last_name>Eslamijouybari</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>drsinaeslami@gmail.com</email>
				<code>122261</code>
				<coreauthor>No</coreauthor>
				<affiliation>Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mansooreh</first_name>
				<middle_name></middle_name>
				<last_name>Mirzaei</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mansoorehmirzaei@yahoo.com</email>
				<code>122262</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Anatomy, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Foruzan</first_name>
				<middle_name></middle_name>
				<last_name>Busaidi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>forouzanbousaeedi@gmail.com</email>
				<code>122263</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran|Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ghazaleh</first_name>
				<middle_name></middle_name>
				<last_name>Rostami</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>ghazale.rostami@gmail.com</email>
				<code>122264</code>
				<coreauthor>No</coreauthor>
				<affiliation>Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Alireza</first_name>
				<middle_name></middle_name>
				<last_name>Rafiei</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>rafiei1710@gmail.com</email>
				<code>122265</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Beyond bioactivity: Chitosan macromolecular coatings on titanium surfaces drive osseointegration and immune suppression through targeted epigenetic regulation</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): To address titanium (Ti) implant failures caused by inadequate osseointegration and persistent inflammation by developing a novel dual-action coating. This coating utilizes a chitosan (CH) matrix to deliver epigenetic pharmaceuticals, 5-azacytidine (AZ) and trichostatin A (TR), onto Ti surfaces (AZ/TR-CH@TI).Materials and Methods: Coating morphology and successful drug integration were validated via FTIR and SEM. Drug release kinetics were evaluated in physiological (pH 7.4) and inflammatory (pH 5.5) conditions over 48 hr. In vitro assessments utilizing MG63 osteoblast-like cells evaluated biocompatibility, anti-inflammatory responses, and osteogenic differentiation using real-time gene expression analysis, functional assays (alkaline phosphatase, Alizarin red), and immunofluorescence. Results: The composite exhibited an intelligent, pH-responsive controlled drug release. AZ/TR-CH@TI significantly enhanced biocompatibility, achieving 124.6% cell proliferation and 89.3% wound closure compared to uncoated controls. Gene expression analysis demonstrated potent anti-inflammatory effects, with TNF-α and IL-6 reduced to 0.31- and 0.35-fold, respectively. Concurrently, it augmented osteogenesis, up-regulating RUNX2 (2.60-fold), BMP2 (4.87-fold), and type-1 collagen (4.15-fold). Assays unequivocally validated comprehensive osteogenic differentiation and significant mineralization.Conclusion: This macromolecular epigenetic drug-loaded CH coating effectively mitigates inflammation while simultaneously stimulating bone formation. The AZ/TR-CH@TI system presents a highly promising therapeutic approach to improve Ti osseointegration for clinical orthopaedic and dental applications.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Anti-inflammatory agents, Biological macromolecules, Chitosan coating, Epigenetic pharmaceuticals, Osteogenic processes, Titanium prosthetics</keyword>
				<start_page>1066</start_page>
				<end_page>1078</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27824.html</web_url>
			<author_list><author>
				<first_name>Rayshmi</first_name>
				<middle_name></middle_name>
				<last_name>Balaji</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>dr.rayshmi28@gmail.com</email>
				<code>122333</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Prosthodontics and Crown &amp; Bridge, Government Dental College and Hospital, Cuddalore District, The Tamilnadu Dr. M.G.R.  Medical University, Tamilnadu, India</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Nagarajan</first_name>
				<middle_name></middle_name>
				<last_name>Mahendirakumar</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>nmk.mds@gmail.com</email>
				<code>122334</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Prosthodontics and Crown &amp; Bridge, Government Dental College and Hospital, Cuddalore District, The Tamilnadu Dr. M.G.R.  Medical University, Tamilnadu</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Vijitha</first_name>
				<middle_name></middle_name>
				<last_name>Dayasekaran</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>vijitha95@gmail.com</email>
				<code>122335</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Prosthodontics and Crown &amp; Bridge, Government Dental College and Hospital, Cuddalore District, The Tamilnadu Dr. M.G.R.  Medical University Tamilnadu</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Sriram</first_name>
				<middle_name></middle_name>
				<last_name>Kaliamoorthy</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>ksrirammds@gmail.com</email>
				<code>122332</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Dentistry, Vinayaka Mission’s Medical College and Hospital, Vinayaka Mission’s Research Foundation (DU), Karaikal, Puducherry, India</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Kavitha</first_name>
				<middle_name></middle_name>
				<last_name>Jayavel</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>kavithajayavel@gmail.com</email>
				<code>122336</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Periodontology, Government Dental College and Hospital, Cuddalore District, TheTamilnadu Dr. M.G.R. Medical University, Tamilnadu, India</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Trigonelline protects against alcohol-induced brain damage by inhibition of oxidative stress, TLR4/NF-κB/proinflammatory cytokines pathway, and apoptosis</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Brain injury is one of the most predominant complications following excessive alcohol consumption. Oxidative, inflammatory, and apoptotic processes are the essential mechanisms involved in alcohol-induced brain damage. Trigonelline is a natural compound that has a variety of pharmacologic activities. The present study investigated the protective effect of trigonelline in alcohol-induced brain injury and its underlying mechanisms.  Materials and Methods: Adult male mice (C57BL/6) were exposed to binge ethanol (6 g/kg/day, by gavage) and treated with trigonelline (50 and 100 mg/kg/day, orally) for 6 days. Mice were sacrificed and the brain tissues were dissected for experimental assessments.  Results: The results showed that trigonelline alleviated alcohol-induced locomotor impairment and brain oxidative damage by decreasing lipid peroxidation and protein oxidation. Trigonelline restored the levels of protective antioxidants (GSH, SOD, and HO-1) and reduced the levels of ICAM-1 and MPO in the brains of mice exposed to alcohol. Trigonelline significantly reduced alcohol-induced brain inflammation by the inhibition of iNOS/NO, TLR4, NF-κB, and proinflammatory cytokines (TNF-α, IL-6, IL-1β, and TGF-β1). Moreover, trigonelline treatment reduced the levels of caspase-3, cytochrome c, and TUNEL positive cells in the brains of alcohol-exposed mice. Conclusion: These findings suggest that trigonelline protects brain against alcohol intoxication by inhibition of oxidative and inflammatory and apoptotic responses. Therefore, trigonelline may serve as a potential therapeutic approach for the protection of brain damage associated with binge alcohol consumption.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Alcohol, Neuroinflammation, Neurotoxicity, TLR4/NF-κB, Trigonelline</keyword>
				<start_page>1079</start_page>
				<end_page>1088</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27861.html</web_url>
			<author_list><author>
				<first_name>Keyvan</first_name>
				<middle_name></middle_name>
				<last_name>Amirshahrokhi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>k.amirshahrokhi@arums.ac.ir</email>
				<code>122490</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Pharmacology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ali</first_name>
				<middle_name></middle_name>
				<last_name>Niapour</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>niapour@gmail.com</email>
				<code>122491</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Anatomical Sciences, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mahsa</first_name>
				<middle_name></middle_name>
				<last_name>Imani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mimani@gmail.com</email>
				<code>122492</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pharmacology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Synthesis, radiolabeling, and biodistribution evaluation of novel hyperbranched polyglycerols-based radiotracers for targeting PSMA in prostate cancer</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Prostate-specific membrane antigen (PSMA) is a valuable target for prostate cancer imaging and therapy. This study aimed to improve the rapid blood clearance and suboptimal tumor uptake and retention of radiolabeled PSMA by developing a hyperbranched polyglycerol (HPG)-based PSMA conjugate.Materials and Methods: HPG was synthesized via a one-step ring-opening multibranching polymerization (ROMBP) technique and sequentially functionalized with a PSMA-targeting ligand and a tris (hydroxypyridinone) (THP) chelator. The final construct was radiolabeled with gallium-68 or technetium-99m. Physicochemical properties, including lipophilicity (log P) and in vitro stability, were evaluated. In vivo biodistribution and imaging were assessed in LNCaP tumor-bearing nude mice using PET/SPECT/CT.Results: The THP-HPGs-PSMA derivative (170 kDa, 5-6 PSMA ligands, and 7-8 THP chelators per polymer molecule) achieved radiochemical purity &gt;99%. [68Ga]Ga THP HPG PSMA had high stability (&gt;95% after 120 min), and log P of -1.56 ± 0.18. Blood uptake was 13.95 ± 0.75 and 11.82 ± 0.88 %ID/g at 30 and 120 min, respectively. Tumor uptake reached 7.12 ± 0.27, 7.40 ± 0.63, and 7.91 ± 0.20 %ID/g at 30, 60, and 120 min, respectively. Clearance was predominantly hepatobiliary with reduced renal excretion. [⁹⁹ᵐTc]Tc-THP-HPG-PSMA showed tumor uptake of 8.74 ± 0.25, 9.41 ± 0.42, and 9.80 ± 0.41 %ID/g at 4, 8, and 16 hr. Blocking studies reduced tumor uptake from 7.12 ± 0.27 to 0.93 ± 0.53 %ID/g.Conclusion: Radiolabeled THP-HPG-PSMA demonstrates improved pharmacokinetics, enhanced tumor uptake, prolonged tumor retention, and favorable tumor-to-blood ratios, indicating strong potential for PSMA-targeted prostate cancer applications.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Chelator, Hyperbranched - polyglycerol, Molecular imaging, PET Imaging, Prostate cancer, PSMA</keyword>
				<start_page>1089</start_page>
				<end_page>1099</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27788.html</web_url>
			<author_list><author>
				<first_name>Sara</first_name>
				<middle_name></middle_name>
				<last_name>Roustaei</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>roustaei.sara@gmail.com</email>
				<code>122168</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mehdi</first_name>
				<middle_name></middle_name>
				<last_name>Akhlaghi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>m-akhlaghi@sina.tums.ac.ir</email>
				<code>122169</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Safura</first_name>
				<middle_name></middle_name>
				<last_name>Jokar</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>jokars@tums.ac.ir</email>
				<code>122170</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Omid</first_name>
				<middle_name></middle_name>
				<last_name>Bavi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>o.bavi@sutech.ac.ir</email>
				<code>122171</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Mechanical Engineering, Shiraz University of Technology, Shiraz, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mehdi</first_name>
				<middle_name></middle_name>
				<last_name>Shafiee Ardestani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>shafieeardestani@gmail.com</email>
				<code>122172</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran|Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Khosrou</first_name>
				<middle_name></middle_name>
				<last_name>Abdi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>khmabdi@tums.ac.ir</email>
				<code>122173</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mona</first_name>
				<middle_name></middle_name>
				<last_name>Mosayebnia</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>m_mosayebnia@yahoo.com</email>
				<code>122174</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pharmaceutical Chemistry and Radiopharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mahboobeh</first_name>
				<middle_name></middle_name>
				<last_name>Asadi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mahboobe.asadi1987@gmail.com</email>
				<code>122175</code>
				<coreauthor>No</coreauthor>
				<affiliation>Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Zahra</first_name>
				<middle_name></middle_name>
				<last_name>Ghiamaty</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>z.ghiamaty@gmail.com</email>
				<code>122176</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mahshid</first_name>
				<middle_name></middle_name>
				<last_name>Kiani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mahshidkiani@gmail.com</email>
				<code>122177</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Davood</first_name>
				<middle_name></middle_name>
				<last_name>Beiki</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>beikidav@sina.tums.ac.ir</email>
				<code>122178</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Nerolidol attenuates cardiac hypertrophy and fibrosis in mice: Modulation of collagen type I, apoptotic and endothelial gene expression</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Cardiac hypertrophy is a major pathological feature of cardiovascular disease worldwide. The beneficial effects of terpenes on cardiovascular diseases are well known. In the current study, the cardioprotective effects of nerolidol (NRD), a sesquiterpene alcohol, were evaluated using an isoproterenol (ISO) induced cardiac hypertrophy mice model. Materials and Methods: This study was performed by using the chronic subcutaneous infusion model of ISO. Male mice were administered NRD (100 mg/kg) orally for 7 days. On the 8th day with the continuation of NRD dosing, mice received subcutaneous (SC) with ISO (10 mg/kg) for the next 14 days. Cardiac functions, including ejection fraction, cardiac output, and fractional shortening were evaluated by trans-thoracic echocardiography, one day after the final treatment. Then, animals were euthanized and hearts were isolated. The mRNA and protein expressions of cardiac hypertrophy, apoptosis, and fibrosis markers in mice hearts were determined. Results: Results showed an increased heart-to-body weight ratio. NRD reduced cardiac hypertrophy by down-regulating the hypertrophic (ANP), apoptotic (Bax/Bcl-2), and fibrotic (Col1a1) markers and prevented cardiac remodeling by up-regulating expression of endothelial nitric oxide synthase (eNOS) and anti-apoptotic (Bcl-xL) protein compared to ISO-treated mice. Combining PCR and western blotting data results demonstrated that NRD reverted the ISO-induced cardiac hypertrophy. Conclusion: These findings suggest that NRD prevents ISO-induced cardiac hypertrophy possibly by elevating the levels of eNOS and Bcl-xL and reducing expression of hypertrophic, apoptotic, and fibrotic markers. Thus, NRD may be used to treat ISO-induced cardiac hypertrophy. ]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Cardiac hypertrophy, echocardiography, Endothelial nitric oxide - synthase, Isoproterenol, Nerolidol</keyword>
				<start_page>1100</start_page>
				<end_page>1106</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27739.html</web_url>
			<author_list><author>
				<first_name>Bushra</first_name>
				<middle_name></middle_name>
				<last_name>Sadaf</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>dr.bushra22@yahoo.com</email>
				<code>121909</code>
				<coreauthor>No</coreauthor>
				<affiliation>Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan|Department of Experimental and Clinical Pharmacology, University of Minnesota, College of Pharmacy, 3-120 Weaver Densford Hall, 308 Harvard St SE, Minneapolis, MN 55455, United States</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Muhammad</first_name>
				<middle_name>Naveed</middle_name>
				<last_name>Mushtaq</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>muhammad.mushtaq2@pharm.uol.edu.pk</email>
				<code>121910</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Waqas</first_name>
				<middle_name></middle_name>
				<last_name>Younis</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>waqas.younis@nyulangone.org</email>
				<code>121911</code>
				<coreauthor>No</coreauthor>
				<affiliation>Division of Endocrinology, Diabetes and Metabolism, New York University, Grossmann School of Medicine, New York, USA</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Benu</first_name>
				<middle_name></middle_name>
				<last_name>George</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>benuaurth@gmail.com</email>
				<code>121912</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Experimental and Clinical Pharmacology, University of Minnesota, College of Pharmacy, 3-120 Weaver Densford Hall, 308 Harvard St SE, Minneapolis, MN 55455, United States</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Irfan</first_name>
				<middle_name></middle_name>
				<last_name>Anjum</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>irfan.scps@stmu.edu.pk</email>
				<code>121913</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Basic Medical Sciences, Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Abdul</first_name>
				<middle_name></middle_name>
				<last_name>Aleem</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>abdul.aleem@pharm.uol.edu.pk</email>
				<code>121914</code>
				<coreauthor>No</coreauthor>
				<affiliation>Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Sacubitril/Valsartan: Breaking barriers in uterine adhesion and boosting pregnancy outcomes by suppressing inflammation and fibrosis</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Intrauterine adhesion (IUA) enhances infertility and is primarily driven by inflammation and fibrosis. Sacubitril/Valsartan (Sac/Val), an angiotensin receptor–neprilysin inhibitor, exhibits anti-inflammatory and anti-fibrotic properties; however, its effects on IUA and reproductive outcomes have not been previously studied.Materials and Methods: A rat model of IUA was established by mechanical endometrial injury. Animals were treated orally with Sac/Val (100 mg/kg/day) for 10 days. Inflammatory cytokine expression, oxidative stress markers, histological changes, and fibrotic indices were evaluated. Endometrial regeneration, embryonic development, pregnancy outcomes, and extra-uterine adhesion formation were also assessed.Results: Sac/Val treatment significantly reduced uterine inflammation, oxidative stress, and collagen deposition, as evidenced by decreased expression of pro-inflammatory cytokines and pro-fibrotic markers. Histological analysis demonstrated improved endometrial regeneration, including increased gland numbers and endometrial thickness. In addition, Sac/Val enhanced embryonic development, improved pregnancy rates, increased the number of live offspring, shortened time to conception, and reduced extra-uterine adhesion formation.Conclusion: Sac/Val enhances regeneration of endometrium and pregnancy outcomes in a rat model of IUA, primarily through suppression of inflammation and fibrosis. Further preclinical and clinical studies are needed to determine the protective functions of Sac/Val for IUA treatment.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Fibrosis, Infertility, Inflammation, pregnancy, Uterine</keyword>
				<start_page>1107</start_page>
				<end_page>1114</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27811.html</web_url>
			<author_list><author>
				<first_name>seyed alireza</first_name>
				<middle_name></middle_name>
				<last_name>Parizadeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>alireza.parizadeh@gmail.com</email>
				<code>122268</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ahmad</first_name>
				<middle_name></middle_name>
				<last_name>Asoodeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>asoodeh@um.ac.ir</email>
				<code>122269</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Majid</first_name>
				<middle_name></middle_name>
				<last_name>Khazaei</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>khazaeim@mums.ac.ir</email>
				<code>122270</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran|Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Seyed Mahdi</first_name>
				<middle_name></middle_name>
				<last_name>Hassanian</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>hasanianmehrm@mums.ac.ir</email>
				<code>122271</code>
				<coreauthor>No</coreauthor>
				<affiliation>Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran|Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Protective efficacy of thymol in testicular ischemia/reperfusion injury in rats: A biochemical and histopathological evaluation</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Testicular torsion represents a critical urological emergency, characterised by the rotation of the testicle around the spermatic cord and the only treatment option to prevent testicular loss is detorsion. Testicular ischemia/reperfusion injury (IRI) may result from ischemia due to torsion and reperfusion due to detorsion, which cause injury as a result of the loss of blood flow to the testicular tissue. Thymol (THY), known for its antioxidant properties, is a phenolic monoterpenoid used in the cosmetic and agricultural industries. The objective of this study was to evaluate the hypothesis that THY can safeguard the testicular tissue in a rat model of testicular IRI.Materials and Methods: Eighteen Wistar-Albino rats were randomly divided into 3 groups: control, IRI, and IRI+THY (100 mg/kg). In order to create the IRI model, a four-hour period of ischemia was initiated by rotating the left testis 720°, which was then followed by a two-hour period of reperfusion. The rats were sacrificed at the six-hour mark, after which biochemical and histopathological analyses were conducted on the excised testicular tissues.Results: THY treatment resulted in a notable improvement in testicular damage, as evidenced by the reduction of IRI-induced histopathological findings and an increase in Johnsen scores. In addition, THY treatment led to a significant decrease in the levels of biomarkers associated with IRI-induced inflammation, oxidative stress and endoplasmic reticulum stress.Conclusion: These initial preclinical findings indicate that THY may confer protection against testicular damage induced by IRI. However, further comprehensive studies are required to substantiate this effect.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Apoptosis, Endoplasmic reticulum-stress, Inflammation, Oxidative stress, Testicular torsion, Thymol</keyword>
				<start_page>1115</start_page>
				<end_page>1121</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27722.html</web_url>
			<author_list><author>
				<first_name>Ahmet</first_name>
				<middle_name></middle_name>
				<last_name>Mentese</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>amentese28@gmail.com</email>
				<code>121811</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Türkiy</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ilke Onur</first_name>
				<middle_name></middle_name>
				<last_name>Kazaz</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>drilke@gmail.com</email>
				<code>121812</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Urology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Türkiye</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Zeynep</first_name>
				<middle_name></middle_name>
				<last_name>Sagnak Yilmaz</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>zeynep.sagnak@hotmail.com</email>
				<code>121813</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Medical Pathology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Türkiye</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Nihal</first_name>
				<middle_name></middle_name>
				<last_name>Turkmen Alemdar</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>trkmn_nhl@hotmail.com</email>
				<code>121814</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Medical Services and Techniques, Vocational School of Health Services, Recep Tayyip Erdogan University, 53100 Rize, Türkiye</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Elif</first_name>
				<middle_name></middle_name>
				<last_name>Ayazoglu Demir</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>eliffayaz@gmail.com</email>
				<code>121815</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Chemistry and Chemical Processing Technologies, Macka Vocational School, Karadeniz Technical University, 61750 Trabzon, Türkiye</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fatih</first_name>
				<middle_name></middle_name>
				<last_name>Colak</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>dr.fatihcolak@hotmail.com</email>
				<code>121816</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Urology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Türkiye</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Selim</first_name>
				<middle_name></middle_name>
				<last_name>Demir</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>selim-demir@hotmail.com</email>
				<code>121810</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Türkiye</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Comparative analysis of second and third-generation nanobody-based CAR-NK cells targeting PSMA in prostate cancer immunotherapy: In silico and in vitro studies</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): The use of CAR technology in the treatment of cancer cells is progressing, as well as the use of CAR T-cell in the treatment of blood malignancies is in the clinical trial stage.  In this study, have compared the second and third generation CAR expressed in NK cells in dealing with prostate cancer cells. Materials and Methods: To optimize the CAR design for detection of NK-92 cells, an in silico approach to select between two tags (Flag and c-Myc tags) was initially employed, ultimately favoring the Flag tag. By using lentiviral particles, transduced NK-92 cells with second- and third-generation CAR constructs were subsequently tested as effector cells against prostate cancer cells expressing the Prostate-Specific Membrane Antigen (PSMA). Then assessed both cytokine secretion and cytotoxic responses. Results: Computational analysis indicated that the NB/Flag/hinge configuration would provide superior PSMA recognition. Flow cytometry confirmed successful CAR expression in 47% of second-generation and 49% of third-generation NK-92 cells. Upon co-culture with PSMA-positive LNCaP cells and PSMA-negative PC-3 cells, the third-generation CAR NK cells demonstrated a noticeably stronger cytotoxic effect. Furthermore, higher levels of IL-2, TNF-α, and IFN-γ secretion were observed in the third-generation CAR group compared to the second.Conclusion: According to the computational studies, NB/Flag/hinge interacts with PSMA primarily through electrostatic forces. More importantly, third-generation CAR NK cells targeting PSMA displayed enhanced cytotoxicity and cytokine production relative to second-generation counterparts, pointing to their greater potential for therapeutic application.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Chimeric antigen receptor, Natural killer cell, Single-domain antibodies (Nanobodies), Prostate-specific membrane antigen (PSMA), Prostatic Neoplasms, OX40 co-stimulatory domain, Molecular dynamics - Simulation</keyword>
				<start_page>1122</start_page>
				<end_page>1130</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27812.html</web_url>
			<author_list><author>
				<first_name>Masoud</first_name>
				<middle_name></middle_name>
				<last_name>Gandomkar Ghalhar</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>gandomkar.m67@gmail.com</email>
				<code>122272</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Arezoo</first_name>
				<middle_name></middle_name>
				<last_name>Karami Vandishi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>arezookarami1372@yahoo.com</email>
				<code>122273</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Tissue Engineering and Applied Cell Science, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Akram</first_name>
				<middle_name></middle_name>
				<last_name>Ramazani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>ramezani1991@yahoo.com</email>
				<code>122274</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fatemeh</first_name>
				<middle_name></middle_name>
				<last_name>Hajari Taheri</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>f.h.taheri@gmail.com</email>
				<code>122275</code>
				<coreauthor>No</coreauthor>
				<affiliation>Food and Drug Laboratory Research Center (FDLRC), Iran Food and Drug Administration (IFDA), MOH &amp; ME, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Zahra</first_name>
				<middle_name></middle_name>
				<last_name>Sharifzadeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>zsharifzadeh@gmail.com</email>
				<code>122276</code>
				<coreauthor>No</coreauthor>
				<affiliation>Hybridoma Lab, Department of Immunology, Pasteur Institute of Iran, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mohsen</first_name>
				<middle_name></middle_name>
				<last_name>Abolhassani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mabolhassani@yahoo.com</email>
				<code>122277</code>
				<coreauthor>No</coreauthor>
				<affiliation>Hybridoma Lab, Department of Immunology, Pasteur Institute of Iran, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Masoud</first_name>
				<middle_name></middle_name>
				<last_name>Soleimani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>soleimani.masoud@gmail.com</email>
				<code>122278</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Tissue Engineering and Applied Cell Science, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Niloofar</first_name>
				<middle_name></middle_name>
				<last_name>Taghipour</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>nilitaghipour@gmail.com</email>
				<code>122279</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Tissue Engineering and Applied Cell Science, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Wytske M</first_name>
				<middle_name></middle_name>
				<last_name>van Weerden</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mahmoud.hassani66@gmail.com</email>
				<code>122280</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mojgan</first_name>
				<middle_name></middle_name>
				<last_name>Bandehpour</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>bandehpourm@gmail.com</email>
				<code>122281</code>
				<coreauthor>No</coreauthor>
				<affiliation>Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mahmoud</first_name>
				<middle_name></middle_name>
				<last_name>Hassani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mahmoud.hassani@yahoo.com</email>
				<code>122282</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran|Department of Molecular Medicine, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Kowsar</first_name>
				<middle_name></middle_name>
				<last_name>Bagherzadeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>bagherzadeh.kw@gmail.com</email>
				<code>122283</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Eye Research Center, Five Senses Health Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article>
			</articleset>
			</journal>